NL-OMON31864已完成不适用
A human phase 0, microdose pharmacokinetic study of [14C]-Org 201745-0, [14C]-Org 244378-0 and [14C]-Org 245021-0 in post-menopausal female volunteers - [14C]-Org 201745, [14C]-Org 244378 and [14C]-Org 245021 Microdosing Study
Organon Nederland BV0 个研究点目标入组 18 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •45-70 years of age
- •amenorrhoe for 18 months
排除标准
- •history of significant disease
研究者
相似试验
已完成
1 期
Testing IMM60 in combination with pembrolizumab in melanoma and non-small cell lung cancerCancerISRCTN80472712niversity of Oxford15
进行中（未招募）
1 期
A scientific experiment on patients, to evaluate the effects of various treatments used for bonemarrowcancer, on cells and genes.EUCTR2011-003791-37-DKDepartment of Haematology, Aalborg University Hospital21
招募中
不适用
First-in-human Phase I dose escalation study assessing safety, tolerability and preliminary efficacy of immunomodulatory nanoparticlesNL-OMON52685Tumor Immunology15
进行中（未招募）
1 期
A Phase 1, First-in-Human, Dose Escalation Study of the JNJ-75348780 Bispecific Antibody Targeting CD3 and CD22 in Participants with NHL and CRelapsed/refractory B-cell Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)CTIS2023-504403-92-00Janssen - Cilag International200
招募中
1 期
Phase I study of optimal dose and pharmacokinetics of a Uracil/Tegafur (UFT) plus oral leucovorin regimen after liver resection for colorectal liver metastasisiver resection for liver metastasis of colorectal cancerJPRN-UMIN000021146Oita university, faculty of medicine, department gastroenterology and pediatric surgery18